The Bypass Angioplasty Revascularization Investigation (BARI) trial: Implications for clinical practice

Patrick L. Whitlow, MD, FACC
Director of Interventional Cardiology at the Cleveland Clinic, a fellow of the American College of Cardiology, and a site principal investigator in the Bypass Angioplasty Revascularization Investigation (BARI).

Address: Patrick L. Whitlow, MD, FACC, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Patrick L. Whitlow, MD, FACC
Director of Interventional Cardiology at the Cleveland Clinic, a fellow of the American College of Cardiology, and a site principal investigator in the Bypass Angioplasty Revascularization Investigation (BARI).

Address: Patrick L. Whitlow, MD, FACC, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Patrick L. Whitlow, MD, FACC
Director of Interventional Cardiology at the Cleveland Clinic, a fellow of the American College of Cardiology, and a site principal investigator in the Bypass Angioplasty Revascularization Investigation (BARI).

Address: Patrick L. Whitlow, MD, FACC, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195